Our Pricing

Understanding Mounjaro Pricing and How to Access the Lowest Price in the UK

Finding the lowest price Mounjaro UK pharmacy can be challenging with so many online providers now stocking tirzepatide. At Cured Pharmacy, we offer transparent upfront pricing from £135.00 with no hidden consultation fees and genuine UK-licensed Mounjaro KwikPens dispensed by our GPhC-registered team led by superintendent pharmacist Tarun Kumar (GPhC 2233073).

How Mounjaro (Tirzepatide) Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, which work synergistically to regulate appetite, slow gastric emptying, and improve insulin sensitivity.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose of tirzepatide achieved an average body weight reduction of 22.5% over 72 weeks, compared to 2.4% in the placebo group [1]. This represents one of the most significant weight loss outcomes observed in clinical trials for any pharmacological intervention, making tirzepatide a highly effective option for eligible patients with a BMI of 30 or above, or 27 with weight-related comorbidities.

The medication is administered as a once-weekly subcutaneous injection using the Mounjaro KwikPen, which contains a pre-filled dose. Treatment typically begins at 2.5mg weekly for four weeks, then escalates gradually to minimise gastrointestinal side effects whilst optimising therapeutic response [2].

Why Mounjaro Prices Vary Across UK Pharmacies

The cost of Mounjaro in the UK varies significantly between providers due to several factors, including wholesale acquisition costs, consultation fees, delivery charges, and individual pharmacy pricing strategies. Some providers advertise headline prices but add mandatory consultation fees or subscription models that inflate the final cost, making true price comparison difficult for patients.

At Cured Pharmacy, we guarantee the lowest price Mounjaro UK pharmacy can offer with complete transparency. Our pricing starts from £135.00 for the 2.5mg starter dose, with all costs displayed upfront before you begin your free online consultation. There are no hidden fees, no subscription lock-ins, and no additional charges for our UK prescriber assessment, which typically takes under three minutes to complete.

We source all Mounjaro pens directly from UK-licensed wholesalers, ensuring every KwikPen is genuine, stored to MHRA standards, and supplied with full patient information leaflets. Our GPhC registration (9012511) means we operate under the same rigorous standards as high-street pharmacies, but our online model allows us to pass savings directly to patients.

What's Included in Our Mounjaro Service

Every Mounjaro order from Cured Pharmacy includes a free clinical consultation with a UK-registered prescriber, discreet packaging with no external branding, tracked delivery to your preferred address, and ongoing support from our pharmacy team. If your prescriber determines Mounjaro isn't suitable based on your medical history, we'll suggest alternative weight loss treatments at no additional cost.

Mounjaro vs Wegovy: Clinical Efficacy and Cost Comparison

Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are injectable GLP-1 receptor agonists licensed by the MHRA for weight management, but they differ in mechanism, efficacy, and pricing. Wegovy activates only the GLP-1 pathway, whilst Mounjaro's dual GIP/GLP-1 action produces greater average weight loss in head-to-head comparisons [3].

The SURMOUNT-2 trial specifically compared tirzepatide to semaglutide in patients with type 2 diabetes and obesity. Participants on the highest tirzepatide dose (15mg) lost an average of 15.7% body weight compared to 9.6% with semaglutide 1mg over 40 weeks [3]. This superior efficacy may justify Mounjaro's higher acquisition cost for patients who haven't achieved their weight loss goals on other treatments.

However, Wegovy remains an excellent first-line option for many patients, particularly those new to GLP-1 therapy or with budget constraints. At Cured Pharmacy, Wegovy starts from £135.00 making it more accessible whilst still delivering clinically meaningful weight loss averaging 14.9% over 68 weeks in the STEP-1 trial [4]. Your UK prescriber will discuss which treatment aligns best with your medical history, weight loss goals, and budget during your consultation.

Choosing Between Mounjaro and Wegovy

The decision between these medications depends on several clinical factors including previous treatment response, comorbidities such as type 2 diabetes, tolerability of gastrointestinal side effects, and cost considerations. Both require a prescription following assessment by a UK prescriber, and neither should be used during pregnancy or in patients with a personal or family history of medullary thyroid carcinoma.

How to Order the Lowest Price Mounjaro UK from Cured Pharmacy

Ordering Mounjaro from Cured Pharmacy takes less than five minutes from start to finish. Begin by clicking 'Start Assessment' on our Mounjaro product page, then complete a short medical questionnaire covering your weight history, current medications, and relevant health conditions. This information is reviewed by a UK-registered prescriber, typically within a few hours during working days.

If your prescriber approves Mounjaro, we'll dispense your prescription from our GPhC-registered pharmacy and arrange discreet delivery to your home or workplace. All packaging is plain with no external indication of contents, and we use tracked courier services to ensure safe arrival. Most orders placed before 3pm Monday to Friday are dispatched the same day, with delivery typically within 1-2 working days across the UK.

Your first prescription will usually be for the 2.5mg starter dose, taken once weekly for four weeks. After this initiation period, your prescriber will review your progress and may increase the dose to 5mg, then subsequently to 7.5mg, 10mg, 12.5mg, or 15mg depending on your response and tolerability. Regular follow-up consultations ensure your treatment remains safe and effective throughout your weight loss journey.

Common Side Effects and How to Manage Them

Like all GLP-1 receptor agonists, Mounjaro commonly causes gastrointestinal side effects, particularly during dose escalation. In clinical trials, nausea affected approximately 25-30% of participants, with diarrhoea, constipation, and abdominal discomfort also frequently reported [1]. These effects typically diminish over several weeks as your body adapts to the medication.

To minimise side effects, eat smaller, more frequent meals rather than large portions, avoid high-fat and spicy foods, stay well hydrated, and inject Mounjaro on the same day each week at a time that suits your routine. If nausea becomes troublesome, your prescriber may recommend temporarily maintaining your current dose for an additional month before escalating, or prescribing an antiemetic such as domperidone for short-term relief.

Serious side effects are rare but require immediate medical attention. These include severe abdominal pain that may indicate pancreatitis, signs of thyroid tumours such as a lump in the neck or persistent hoarseness, and symptoms of gallbladder disease including yellowing of the skin or eyes [2]. Contact your GP or NHS 111 immediately if you experience any of these symptoms whilst taking Mounjaro.

When Mounjaro May Not Be Suitable

Mounjaro is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, during pregnancy and breastfeeding, and in those with severe gastrointestinal disease. Your UK prescriber will assess your full medical history during consultation to ensure Mounjaro is safe and appropriate for you.

Alternative Weight Loss Treatments Available at Cured Pharmacy

If Mounjaro isn't suitable or you're looking for a lower-cost option whilst assessing your tolerance to weight loss medication, Cured Pharmacy stocks a comprehensive range of MHRA-licensed alternatives. Saxenda (liraglutide) is a daily GLP-1 injection that has been available in the UK since 2015, offering proven efficacy with an average 8% weight loss over 56 weeks in the SCALE trial [5].

For patients preferring oral medication, Orlistat works by blocking approximately 30% of dietary fat absorption in the intestine. Available as generic Orlistat or the branded version Xenical, this treatment is particularly effective when combined with a reduced-calorie diet and can produce 5-10% weight loss over six months [6]. Orlistat requires less intensive monitoring than injectable treatments and costs significantly less, making it an accessible first-line option for many patients.

We also offer Mysimba (naltrexone/bupropion combination) for patients who haven't responded to other treatments, and we're accepting pre-orders for Wegovy oral tablets (semaglutide pill), expected to launch in the UK in 2025. Every treatment requires a clinical assessment by our UK prescribers, who will recommend the most appropriate option based on your individual circumstances, medical history, and weight loss goals.

Combining Medication with Lifestyle Changes

All weight loss medications work best when combined with sustainable dietary changes and increased physical activity. Your prescriber will provide guidance on nutrition and exercise during your consultation, and we recommend working with a registered dietitian if you need structured support. The NHS provides free resources through their weight loss plan, which can complement your pharmacological treatment effectively.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Eli Lilly and Company. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/14298
3. Garvey, W. T., Frias, J. P., Jastreboff, A. M., et al. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet, 402(10402), 613–626. https://doi.org/10.1016/S0140-6736(23)01200-X
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892
6. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, dietary changes, and physical activity levels.